If the amendment requires approval from the Reviewing HREC, submit the request for amendment to the Reviewing HREC (according to their instructions) first. Once the amendment is approved, submit a request for amendment to the Eye and Ear Research Office using the Site Governance Amendment Request Form on ERM.
The Site Governance Amendment Request form can be used to notify the Research Office of either:
an amendment that has been approved by the reviewing ethics committee
a site specific governance-only amendment that does not require ethical approval (e.g., change of research team or site specific PICF).
Submission instructions:
Amendments can be submitted at any time as follows:
– Eye and Ear site specific research governance – all post authorisation project management must be submitted via ERM using SSA notification forms.
Annual Progress, Safety and Final Reports
All research projects are monitored annually with a Progress Report and a Final Report at the completion of the project.
Some research projects may require more frequent reporting or additional reporting. Please refer to the letter of governance authorisation regarding any specific reporting requirements.
Submit a copy at least annually by the date of approval of:
Reviewing HREC Progress Report, with acknowledgement
Progress Report – Site Form (via ERM)
Submit at least annually by the date of approval of:
Annual Safety Report
Submit a Final Report at the completion of the study or if discontinued early.
Reviewing HREC Progress Report
Submission instructions:
Submit the relevant Report as directed as follows:
Eye and Ear site specific research governance – all progress reports must be submitted via ERM using SSA notification forms.
Monitoring and Safety Reporting (Adverse Events and Breaches)
The Eye and Ear has adopted the following guidelines from 1 April 2019
NHMRC Guidance: Safety monitoring and reporting in clinical trials involving therapeutic goods (NHMRC; November 2016)
NHMRC Guidance: Risk-based management and monitoring of Clinical Trials involving Therapeutic Goods (NHMRC; 2018)
NHMRC Guidance Reporting of Serious Breaches of Good Clinical Practice (GDP) or the Protocol for Trials Involving Therapeutic Goods (NHMRC; 2018)
NHMRC Guidance Data Safety Monitoring Boards (DSMBs) (NHMRC; 2018)
All guidelines are available from the NHMRC website.